Lepu Medical Technology (Beijing) Co., Ltd.

SZSE:300003 Stock Report

Market Cap: CN¥21.8b

Lepu Medical Technology (Beijing) Past Earnings Performance

Past criteria checks 1/6

Lepu Medical Technology (Beijing)'s earnings have been declining at an average annual rate of -7.8%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been declining at an average rate of 0.2% per year. Lepu Medical Technology (Beijing)'s return on equity is 3.9%, and it has net margins of 10.9%.

Key information

-7.8%

Earnings growth rate

-8.7%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate-0.2%
Return on equity3.9%
Net Margin10.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Lepu Medical Technology (Beijing) (SZSE:300003) Is Reinvesting At Lower Rates Of Return

Dec 03
Lepu Medical Technology (Beijing) (SZSE:300003) Is Reinvesting At Lower Rates Of Return

Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly

Nov 15
Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly

Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 28
Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump

Oct 18
Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump

Investors Give Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Shares A 26% Hiding

Sep 02
Investors Give Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Shares A 26% Hiding

News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat

Aug 31
News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat

Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Aug 27
Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Aug 16
Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Jun 23
Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

May 31
Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

May 13
Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Feb 28
Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Revenue & Expenses Breakdown

How Lepu Medical Technology (Beijing) makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SZSE:300003 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246,5067072,157762
30 Jun 247,0629942,258794
31 Mar 247,4651,1432,305847
31 Dec 237,9801,2582,467879
30 Sep 239,1071,7472,777960
30 Jun 239,5771,8972,803959
31 Mar 2310,4982,2542,790974
31 Dec 2210,6092,2042,802957
30 Sep 229,7871,6082,768975
30 Jun 229,4731,2622,741974
31 Mar 2210,4601,5392,859955
01 Jan 2210,6601,7192,871908
30 Sep 2110,2861,7502,540875
30 Jun 2110,3212,3872,714812
31 Mar 219,1212,1442,584774
31 Dec 208,0391,8022,484736
30 Sep 208,3032,0862,621653
30 Jun 208,1121,7102,599591
31 Mar 207,5841,5262,694563
31 Dec 197,7961,7252,792544
30 Sep 197,6521,6872,864469
30 Jun 197,3231,5642,791455
31 Mar 196,7991,4982,643405
31 Dec 186,3561,2192,481376
30 Sep 185,8321,3042,137345
30 Jun 185,3101,2141,750406
31 Mar 184,9429701,644315
31 Dec 174,5388991,467235
30 Sep 174,2348741,336154
30 Jun 173,9747971,3330
31 Mar 173,7017341,2250
31 Dec 163,4686791,1300
30 Sep 163,3186491,0340
30 Jun 163,1136109420
31 Mar 162,9385698510
31 Dec 152,7695217810
30 Sep 152,4195206710
30 Jun 152,2085006220
31 Mar 151,9344585640
31 Dec 141,6694235280
30 Sep 141,5784055100
30 Jun 141,4903855040
31 Mar 141,3753624940
31 Dec 131,3033624760

Quality Earnings: 300003 has high quality earnings.

Growing Profit Margin: 300003's current net profit margins (10.9%) are lower than last year (19.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 300003's earnings have declined by 7.8% per year over the past 5 years.

Accelerating Growth: 300003's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300003 had negative earnings growth (-59.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).

Return on Equity

High ROE: 300003's Return on Equity (3.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 14:52
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lepu Medical Technology (Beijing) Co., Ltd. is covered by 26 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Pei ChengChina Galaxy Securities Co., Ltd.
Yuan GaoChina International Capital Corporation Limited